<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Pfizer&#8217;s Norvasc Patent Finally Goes Down After Taking Plenty of Punches</title>
	<atom:link href="http://www.patentbaristas.com/archives/2007/03/22/pfizers-norvasc-patent-finally-goes-down-after-taking-plenty-of-punches/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.patentbaristas.com/archives/2007/03/22/pfizers-norvasc-patent-finally-goes-down-after-taking-plenty-of-punches/</link>
	<description>Freshly Brewed Bio/Pharma Chat. Served Up Daily.</description>
	<lastBuildDate>Wed, 10 Mar 2010 16:00:30 -0500</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Patent Baristas &#187; Patents Found Invalid Against One Party Are Unenforceable Against Another Party</title>
		<link>http://www.patentbaristas.com/archives/2007/03/22/pfizers-norvasc-patent-finally-goes-down-after-taking-plenty-of-punches/comment-page-1/#comment-32197</link>
		<dc:creator>Patent Baristas &#187; Patents Found Invalid Against One Party Are Unenforceable Against Another Party</dc:creator>
		<pubDate>Fri, 07 Dec 2007 03:29:26 +0000</pubDate>
		<guid isPermaLink="false">http://www.patentbaristas.com/archives/2007/03/22/pfizers-norvasc-patent-finally-goes-down-after-taking-plenty-of-punches/#comment-32197</guid>
		<description>[...] reader on Philip Brooks&#8217; Patent Infringement Updates asked about the downstream effects of the CAFC decision invalidating Pfizer’s Norvasc® patent (U.S. Patent No. 4,879,303). In this appeal, the CAFC held that the district court erred in holding [...]</description>
		<content:encoded><![CDATA[<p>[...] reader on Philip Brooks&#8217; Patent Infringement Updates asked about the downstream effects of the CAFC decision invalidating Pfizer’s Norvasc® patent (U.S. Patent No. 4,879,303). In this appeal, the CAFC held that the district court erred in holding [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
